Author(s): Lepoivre M, Chenais B, Yapo A, Lemaire G, Thelander L, et al.
The murine adenocarcinoma cell line TA 3 synthesized nitrite from L-arginine upon stimulation with gamma-interferon (IFN-gamma) associated with tumor necrosis factor (TNF), and/or bacterial lipopolysaccharide (LPS), but not with IFN-gamma, TNF, or LPS added separately. Induction of the NO2(-)-generating activity caused an inhibition of DNA synthesis in TA 3 cells. This inhibition was prevented by the L-arginine analog N omega-nitro-L-arginine, which inhibited under the same conditions nitrite production by TA 3 cells. The TA 3 M2 subclone, selected for enhanced ribonucleotide reductase activity, was found to be less sensitive than the wild phenotype TA 3 WT to the cytostatic activity mediated by the NO2(-)-generating system. Cytosolic preparations from TA 3 M2 cells treated for 24 or 48 h with IFN-gamma, TNF, and LPS exhibited a reduced ribonucleotide reductase activity, compared to untreated control cells. No reduction in ribonucleotide reductase activity was observed when N omega-nitro-L-arginine was added to treated cells. Addition of L-arginine, NADPH, and tetrahydrobiopterin into cytosolic extracts from 24-h treated TA 3 M2 cells triggered the synthesis of metabolic products from the NO2(-)-generating pathway. This resulted in a dramatic inhibition of the residual ribonucleotide reductase activity present in the extracts. The inhibition was reversed by NG-monomethyl-L-arginine, another specific inhibitor of the NO2(-)-generating activity. No L-arginine-dependent inhibition of ribonucleotide reductase activity was observed using extracts from untreated cells that did not express NO2(-)-generating activity. These results demonstrate that, in an acellular preparation, molecules derived from the NO2(-)-generating pathway exert an inhibitory effect on the ribonucleotide reductase enzyme. This negative action might explain the inhibition of DNA synthesis induced in adenocarcinoma cells by the NO2(-)-generating pathway.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/2117605
Author(s): Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, et al.
Author(s): Burdon KP, Langefeld CD, Wagenknecht LE, Carr JJ, Freedman BI, et al.
Author(s): Moncada S, Higgs A
Author(s): Loscalzo J, Welch G
Author(s): Cooke JP, Tsao PS
Author(s): Star RA
Author(s): Garg UC, Hassid A
Author(s): Prabhakar SS
Author(s): Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, et al.
Author(s): Boulton AJ
Author(s): Taverna MJ, Elgrably F, Selmi H, Selam JL, Slama G
Author(s): Costacou T, Chang Y, Ferrell RE, Orchard TJ
Author(s): Brouet A, Sonveaux P, Dessy C, Balligand JL, Feron O
Author(s): Nosikov VV
Author(s): Bazzaz JT, Amoli MM, Pravica V, Chandrasecaran R, Boulton AJ, et al.
Author(s): Taverna MJ, Sola A, Guyot-Argenton C, Pacher N, Bruzzo F, et al.
Author(s): Manea SA, Robciuc A, Guja C, Heltianu C
Author(s): Mehrab-Mohseni M, Tabatabaei-Malazy O, Hasani-Ranjbar S, Amiri P, Kouroshnia A, et al.
Author(s): Wild S, Roglic G, Green A, Sicree R, King H
Author(s): Basu A, Mukherjee N, Roy S, Sengupta S, Banerjee S, et al.
Author(s): Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, et al.
Author(s): Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE
Author(s): Hattersley AT, McCarthy MI
Author(s): Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Sud K, et al.
Author(s): Neale BM, Sham PC
Author(s): Ross R
Author(s): Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, et al.
Author(s): Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, et al.
Author(s): Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, et al.
Author(s): Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, et al.
Author(s): Yoshimura T, Yoshimura M, Tabata A, Shimasaki Y, Nakayama M, et al.
Author(s): Cheema BS, kohli HS, Sharma R, Bhansali A, Khullar M